SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999; 44: 989990.
  • 2
    Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997; 337: 956962.
  • 3
    Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997; 337: 949955.
  • 4
    Recht A, Come SE, Henderson I, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996; 334: 13561361.
  • 5
    Buchholz TA, Austin-Seymour MM, Moe RE, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1993; 26: 2335.
  • 6
    Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet. 2000; 355: 949955.
  • 7
    Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000; 18: 16061613.
  • 8
    Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991; 21: 355360.
  • 9
    Macquart-Moulin G, Viens P, Genre D, et al. Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and daily organization. Cancer. 1999; 85: 21902199.
  • 10
    Abner AL, Recht A, Vicini F, et al. Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1991; 21: 331338.
  • 11
    International Union Against Cancer. TNM classification of malignant tumours. SobinLH, WittekindCH, editors. New York: Wiley-Liss, Inc., 1997; 123130.
  • 12
    Mayers C, Panzarella T, Tannock IF. Analysis of the prognostic effects of inclusion in a clinical trial and of myelosupression on survival after adjuvant chemotherapy for breast carcinoma. Cancer. 2001; 91: 22462257.
  • 13
    Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31: 13411346.
  • 14
    SAS/STAT computer program. User's guide. 8th edition. Cary, NC: SAS Institute Inc., 1999.
  • 15
    StatXact computer program. 4th edition. Cambridge, MA: Cytel Software Corporation, 1999.
  • 16
    Engelsman E, Klijn JC, Rubens RD, et al. “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808). Eur J Cancer. 1991; 27: 966970.
  • 17
    Leonard CE, Wood ME, Zhen B, et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? J Clin Oncol. 1995; 13: 29062915.
  • 18
    Wallgren A, Bernier J, Gelber RD, et al. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. Int J Radiat Oncol Biol Phys. 1996; 35: 649659.
  • 19
    Clarke DH, Lê MG, Sarrazin D, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1985; 11: 137145.
  • 20
    Slotman BJ, Meyer OW, Njo KH, Karim AB. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol. 1994; 30: 206212.
  • 21
    International Breast Cancer Study Group. Duration and reintroduction of adjuvant chemotherapy for node positive premenopausal breast cancer patients. J Clin Oncol. 1996; 14: 18851894.
  • 22
    International Breast Cancer Study Group. Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients. J Clin Oncol. 1997; 15: 13851394.
  • 23
    Denham JW, Hamilton CS, Christie D, et al. Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer-toxicity and dose modification: a Trans-Tasman Radiation Oncology Group multi-institution study. Int J Radiat Oncol Biol Phys. 1995; 31: 305313.
  • 24
    Lamb D, Atkinson C, Joseph D, et al. Simultaneous adjuvant radiotherapy and chemotherapy for Stage I and II breast cancer. Australas Radiol. 1999; 43: 220226.
  • 25
    Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 1998; 352: 930942.
  • 26
    Protière C, Viens P, Genre D, et al. Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancer. Ann Oncol. 2000; 11: 3945.
  • 27
    Tannock IF. Treatment of cancer with radiation and drugs. J Clin Oncol. 1996; 14: 31563174.
  • 28
    Cox JD. Chemoradiation for malignant epithelial tumors. Cancer Radiother. 1998; 2: 711.
  • 29
    Buchholz TA, Hunt KK, Amosson CM, et al. Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am. 1999; 5: 159164.
  • 30
    Fernando IN, Powles TJ, Ashley S, Grafton D, Harmer CL, Ford HT. An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery. Clin Oncol (R Coll Radiol). 1996; 8: 234238.
  • 31
    Bentzen SM, Overgaard M, Thames HD, Christensen JJ, Overgaard J. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol. 1989; 56: 711715.
  • 32
    Serin D, Aimard L, Kirscher S, et al. Traitement adjuvant des cancers du sein par radiochimiothérapie concomitante: étude de faisabilité d'une nouvelle alternative stratégique dans les stades I et II. Bull Cancer. 1997; 84: 247253.
  • 33
    Dubey A, Recht A, Come SE, et al. Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study. Int J Radiat Oncol Biol Phys. 1999; 45: 877884.
  • 34
    Markiewicz DA, Schultz DJ, Haas JA, et al. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. Int J Radiat Oncol Biol Phys. 1996; 35: 661668.
  • 35
    Bonadonna G, Zambetti M, Valagussa P. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results. JAMA. 1995; 273: 542547.